Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Long-Term Investments (2018)

Historic Long-Term Investments for Akebia Therapeutics (AKBA) over the last 1 years, with Q4 2018 value amounting to $245000.0.

  • Akebia Therapeutics' Long-Term Investments changed N/A to $245000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $245000.0, marking a year-over-year change of. This contributed to the annual value of $245000.0 for FY2018, which is N/A changed from last year.
  • According to the latest figures from Q4 2018, Akebia Therapeutics' Long-Term Investments is $245000.0.
  • Akebia Therapeutics' Long-Term Investments' 5-year high stood at $245000.0 during Q4 2018, with a 5-year trough of $245000.0 in Q4 2018.